DelveInsight's,“ Advanced Melanoma Pipeline Insight 2025 ” report provides comprehensive insights about 55+ companies and 60+ pipel ...

KPV peptide, a small bioactive tripeptide, has garnered increasing attention within various research domains due to its ...

Patients who do not possess the MC1R risk alleles have a lower probability, but are not entirely safe from developing UV-related cutaneous neoplasms, and thus, should be counselled accordingly.

a targeted alpha-particle therapy (TAT), as monotherapy in patients with histologically confirmed melanoma and positive melanocortin 1 receptor (MC1R) imaging scans. Patients in this cohort are ...

PL8177 is a potent, selective agonist at the human melanocortin-1 receptor (MC1R), with sub-nanomolar affinity binding and EC50 functional values. Palatin data demonstrates that their oral formulation ...